Related Experiment Video
Updated: May 30, 2026
05:39
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
Cognition in neuromuscular disease.
Angela Giacoletti Argento1, Jacqueline Kaufman
1University of Michigan Health Systems, Ann Arbor, MI, USA.
Journal of Pediatric Rehabilitation Medicine
|July 28, 2011
Summary
Neuromuscular diseases impact more than physical health, affecting cognition and psychosocial well-being. This paper explores neurocognitive risks and offers school-based support strategies for affected children and adolescents.
Area of Science:
- Neurology
- Neuropsychology
- Pediatrics
Background:
- Neuromuscular diseases (NMDs) predominantly impact physical function.
- Cognitive and psychosocial effects of NMDs are often significant but underrecognized.
- Understanding these effects is crucial for holistic patient care.
Purpose of the Study:
- To provide an overview of specific neuromuscular diseases and their associated neurocognitive risks.
- To present a framework for understanding neuropsychological differences in pediatric NMD patients.
- To identify research gaps and offer practical guidelines for school-based functioning.
Main Methods:
- Literature review of neuromuscular diseases and neurocognitive outcomes.
- Development of a heuristic model for neuropsychological assessment in pediatric NMD.
- Synthesis of current research to inform practical recommendations.
Main Results:
- NMDs are associated with a range of neurocognitive risks.
- Specific patterns of neuropsychological differences exist in children and adolescents with NMDs.
- Evidence-based guidelines for school functioning can mitigate challenges.
Conclusions:
- Cognitive and psychosocial aspects are integral to managing NMDs.
- A structured approach is needed to address neurocognitive challenges in pediatric NMD.
- Interdisciplinary collaboration is key to optimizing outcomes for affected students.
More Related Videos
09:24Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
Published on: April 17, 2017
09:07Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles
Published on: September 25, 2015
Related Concept Videos
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...